DOUBLING THE INFLIXIMAB DOSE VERSUS HALVING THE INFUSION INTERVALS IN CROHN'S DISEASE PATIENTS WITH LOSS OF RESPONSE

(1) Sheba Medical Center

(2) University of Michigan Medical Center

(3) University of California San Francisco

(4) Herlev Hospital, University of Copenhagen

(5) Evangelismos Hospital

(6) Cleveland Clinic

(7) Columbia university Presbyterian hospital

(8) University of Miami Miller School of Medicine

(9) St. Marks Hospital

(10) Semmelweis University

(11) Mater Dei Hospital

(12) Hadassah Medical Center

(13) Medicinsk afdeling Vejle, Sygehus Hospital

(14) Erasmus Medical Center

(15) Medical School of Ioannina

(16) Northwestern University Feinberg School of Medicine

(17) Tel-Aviv Medical Center

(18) Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)



This item was part of the Anti-TNF in IBD: Real-life experience session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A71

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2011